1
Clinical Trials associated with Autologous Gene-edited Muscle Stem Cells(Charite University, Berlin, Germany)Phase 1/2a First-in-human Trial Evaluating Autologous Gene-edited Muscle Stem Cells in Limb Girdle Muscular Dystrophies (GenPHSats-bASKet)
This study is an investigator initiated first-in-human interventional open label phase 1/2a clinical trial investigating an ATMP in the orphan disease LGMD to evaluate safety and efficacy.
100 Clinical Results associated with Autologous Gene-edited Muscle Stem Cells(Charite University, Berlin, Germany)
100 Translational Medicine associated with Autologous Gene-edited Muscle Stem Cells(Charite University, Berlin, Germany)
100 Patents (Medical) associated with Autologous Gene-edited Muscle Stem Cells(Charite University, Berlin, Germany)
100 Deals associated with Autologous Gene-edited Muscle Stem Cells(Charite University, Berlin, Germany)